5 amino 1mq 10mg reconstitution 5-Amino-1MQ 5-Amino-1MQ – 10MG – Ascension

Why Compounding Access Is Not an Established Path Positioning in the Metabolic Medicine Conversation For physicians fielding patient questions about 5-amino-1MQ, the appropriate framing: Promising mechanism with solid preclinical rationale Early clinical development human efficacy and safety not yet well characterized No legitimate clinical access pathway in the United States as of 2026 Alternative evidence-based options exist for the underlying metabolic optimization goals patients typically pursue Key Takeaways 5-amino-1MQ is a small-molecule NNMT inhibitor, not a peptide

For 5 mg vials, 2 mL of water works well

Post-surgical protocols may use 500mcg twice daily for the first week, then once daily for 35 weeks

What Is MICC Prescribed For

60 Two studies used methyl-B12, 58,60 the others did not mention the form